Combined effects of PLGA and vascular endothelial growth factor promote the healing of non-diabetic and diabetic wounds

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 8, 2015, Pages 1975-1984

  Chereddy, Kiran Kumar ^a   Lopes, Alessandra ^a   Koussoroplis, Salome ^a   Payen, Valéry ^a   Moia, Claudia ^b   Zhu, Huijun ^b   Sonveaux, Pierre ^a   Carmeliet, Peter ^c   des Rieux, Anne ^a   Vandermeulen, Gaëlle ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CRANFIELD UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Diabetic wound healing; Lactate; Nanoparticles; Poly(lactic co glycolic acid) (PLGA); VEGF

Indexed keywords

NANOPARTICLES; TISSUE REGENERATION;

COMBINATION THERAPY; DIABETIC WOUNDS; GROWTH FACTOR THERAPIES; LACTATE; POLY(LACTIC-CO-GLYCOLIC ACID); RE-EPITHELIALIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF;

ENDOTHELIAL CELLS;

COLLAGEN; POLYGLACTIN; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG; LACTIC ACID; NANOPARTICLE; PEROXIDASE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; EPITHELIZATION; FEMALE; GRANULATION TISSUE; KERATINOCYTE; MOUSE; NANOENCAPSULATION; NONHUMAN; WOUND HEALING; ANIMAL; CELL LINE; DIABETES COMPLICATIONS; DRUG EFFECTS; FIBROBLAST; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; CELL LINE; CELL PROLIFERATION; COLLAGEN; DIABETES COMPLICATIONS; FEMALE; FIBROBLASTS; HUMANS; KERATINOCYTES; LACTIC ACID; MICE; NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; PEROXIDASE; POLYGLYCOLIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84951171178     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.07.006     Document Type: Article

References (33)

1. Velnar T., Bailey T., Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009, 37:1528-1542.
2. Guo S., DiPietro L.A. Factors affecting wound healing. J Dent Res 2010, 89:219-229.
3. Sen C.K., Gordillo G.M., Roy S., Kirsner R., Lambert L., Hunt T.K., et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 2009, 17:763-771.
4. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005, 366:1736-1743.
5. Emmerson E., Campbell L., Davies F.C.J., Ross N.L., Ashcroft G.S., Krust A., et al. Insulin-like growth factor-1 promotes wound healing in estrogen-deprived mice: new insights into cutaneous IGF-1R/ER[alpha] cross talk. J Investig Dermatol 2012, 132:2838-2848.
6. Johnson N.R., Wang Y. Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing. J Control Release 2013, 166:124-129.
7. Johnson K.E., Wilgus T.A. Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Adv Wound Care 2014, 3:647-661.
8. Werner S.G.R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
9. Bao P., Kodra A., Tomic-Canic M., Golinko M.S., Ehrlich H.P., Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009, 153:347-358.
10. Galiano R.D., Tepper O.M., Pelo C.R., Bhatt K.A., Callaghan M., Bastidas N., et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004, 164:1935-1947.
11. Saaristo A., Suominen E., Yla-Herttuala S. Gene transfer as a tool to induce therapeutic vascular growth in plastic surgery. Handchir Mikrochir Plast Chir 2005, 37:375-382.
12. Danhier F., Ansorena E., Silva J.M., Coco R., Le Breton A., Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 2012, 161:505-522.
13. Porporato P.E., Payen V.L., De Saedeleer C.J., Preat V., Thissen J.P., Feron O., et al. Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice. Angiogenesis 2012, 15:581-592.
14. Trabold O., Wagner S., Wicke C., Scheuenstuhl H., Hussain M.Z., Rosen N., et al. Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing. Wound Repair Regen 2003, 11:504-509.
15. Chereddy K.K., Coco R., Memvanga P.B., Ucakar B., des Rieux A., Vandermeulen G., et al. Combined effect of PLGA and curcumin on wound healing activity. J Control Release 2013, 171:208-215.
16. Chereddy K.K., Her C.-H., Comune M., Moia C., Lopes A., Porporato P.E., et al. PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing. J Control Release 2014, 194:138-147.
17. Golub J.S., Kim Y.-t., Duvall C.L., Bellamkonda R.V., Gupta D., Lin A.S., et al. Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol Heart Circ Physiol 2010, 298:1959-1965.
18. des Rieux A., Ucakar B., Mupendwa B.P.K., Colau D., Feron O., Carmeliet P., et al. 3D systems delivering VEGF to promote angiogenesis for tissue engineering. J Control Release 2011, 150:272-278.
19. Coco R., Plapied L., Pourcelle V., Jérôme C., Brayden D.J., Schneider Y.-J., et al. Drug delivery to inflamed colon by nanoparticles: comparison of different strategies. Int J Pharm 2013, 440:3-12.
20. Chacón M., Molpeceres J., Berges L., Guzmán M., Aberturas M.R. Stability and freeze-drying of cyclosporine loaded poly(d,l-lactide-glycolide) carriers. Eur J Pharm Sci 1999, 8:99-107.
21. Steinstraesser L., Lam M.C., Jacobsen F., Porporato P.E., Chereddy K.K., Becerikli M., et al. Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing. Mol Ther 2013, 22:734-742.
22. Olaso E., Lin H.-C., Wang L.-H., Friedman S. Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrix remodeling. Fibrogenesis Tissue Repair 2011, 4:5.
23. Vanacker J., Luyckx V., Dolmans M.-M., Des Rieux A., Jaeger J., Van Langendonckt A., et al. Transplantation of an alginate-matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells. Biomaterials 2012, 33:6079-6085.
24. Hasmann A., Wehrschuetz-Sigl E., Marold A., Wiesbauer H., Schoeftner R., Gewessler U., et al. Analysis of myeloperoxidase activity in wound fluids as a marker of infection. Ann Clin Biochem 2013, 50:245-254.
25. Mundargi R.C., Babu V.R., Rangaswamy V., Patel P., Aminabhavi T.M. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release 2008, 125:193-209.
26. Fredenberg S., Wahlgren M., Reslow M., Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - A review. Int J Pharm 2011, 415:34-52.
27. Wilgus T.A., Matthies A.M., Radek K.A., Dovi J.V., Burns A.L., Shankar R., et al. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 2005, 167:1257-1266.
28. Zhu J.-W., Wu X.-J., Luo D., Lu Z.-F., Cai S.-Q., Zheng M. Activation of VEGFR-2 signaling in response to moderate dose of ultraviolet B promotes survival of normal human keratinocytes. Int J Biochem Cell Biol 2012, 44:246-256.
29. Brem H., Kodra A., Golinko M.S., Entero H., Stojadinovic O., Wang V.M., et al. Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. J Investig Dermatol 2009, 129:2275-2287.
30. Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem 2013, 153:13-19.
31. Koch S., Tugues S., Li X., Gualandi L., Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J 2011, 437:169-183.
32. Kumar V.B.S., Viji R.I., Kiran M.S., Sudhakaran P.R. Endothelial cell response to lactate: implication of PAR modification of VEGF. J Cell Physiol 2007, 211:477-485.
33. Byrne A.M., Bouchier-Hayes D.J., Harmey J.H. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005, 9:777-794.